Literature DB >> 21743029

The oncogene Trop2 regulates fetal lung cell proliferation.

Annie R A McDougall1, Stuart B Hooper, Valerie A Zahra, Foula Sozo, Camden Y Lo, Timothy J Cole, Tim Doran, Megan J Wallace.   

Abstract

The factors regulating growth of the developing lung are poorly understood, although the degree of fetal lung expansion is critical. The oncogene Trop2 (trophoblast antigen 2) is upregulated during accelerated fetal lung growth, and we hypothesized that it may regulate normal fetal lung growth. We investigated Trop2 expression in the fetal and neonatal sheep lung during accelerated and delayed lung growth induced by alterations in fetal lung expansion, as well as in response to glucocorticoids. Trop2 expression was measured using real-time PCR and localized spatially using in situ hybridization and immunofluorescence. During normal lung development, Trop2 expression was higher at 90 days gestational age (GA; 4.0 ± 0.8) than at 128 days GA (1.0 ± 0.1), decreased to 0.5 ± 0.1 at 142 days GA (full term ∼147 days GA), and was positively correlated to lung cell proliferation rates (r = 0.953, P < 0.005). Trop2 expression was regulated by fetal lung expansion, but not by glucocorticoids. It was increased nearly threefold by 36 h of increased fetal lung expansion (P < 0.05) and was reduced to ∼55% of control levels by reduced fetal lung expansion (P < 0.05). Trop2 expression was associated with lung cell proliferation during normal and altered lung growth, and the TROP2 protein colocalized with Ki-67-positive cells in the fetal lung. TROP2 was predominantly localized to fibroblasts and type II alveolar epithelial cells. Trop2 small interfering RNA decreased Trop2 expression by ∼75% in cultured fetal rat lung fibroblasts and decreased their proliferation by ∼50%. Cell viability was not affected. This study demonstrates that TROP2 regulates lung cell proliferation during development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21743029     DOI: 10.1152/ajplung.00063.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

1.  TACSTD2 upregulation is an early reaction to lung infection.

Authors:  Sára Lenárt; Peter Lenárt; Lucia Knopfová; Hana Kotasová; Vendula Pelková; Veronika Sedláková; Ondřej Vacek; Jana Pokludová; Vladimír Čan; Jan Šmarda; Karel Souček; Aleš Hampl; Petr Beneš
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

2.  Trop2 gene: a novel target for cervical cancer treatment.

Authors:  Xiaoqi Liu; Siqi Li; Faping Yi
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-10       Impact factor: 4.553

Review 3.  Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications.

Authors:  Anna Shvartsur; Benjamin Bonavida
Journal:  Genes Cancer       Date:  2015-03

Review 4.  Trop2: Jack of All Trades, Master of None.

Authors:  Sára Lenárt; Peter Lenárt; Jan Šmarda; Ján Remšík; Karel Souček; Petr Beneš
Journal:  Cancers (Basel)       Date:  2020-11-11       Impact factor: 6.639

5.  Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus.

Authors:  Sascha Hoppe; Lydia Meder; Florian Gebauer; Roland T Ullrich; Thomas Zander; Axel M Hillmer; Reinhard Buettner; Patrick Plum; Julian Puppe; Wolfram Malter; Alexander Quaas
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

6.  TROP2 methylation and expression in tamoxifen-resistant breast cancer.

Authors:  Stephanie M Zimmers; Eva P Browne; Kristin E Williams; Rahul M Jawale; Christopher N Otis; Sallie S Schneider; Kathleen F Arcaro
Journal:  Cancer Cell Int       Date:  2018-07-06       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.